ConductScience.org, home

Paper1850498

Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).

Warrell RP and 9 others. N Engl J Med, 1991. Cited by 1,289 papers, by iCite.

Cite this record

ConductScience Library. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). Papers, record 1850498. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1850498

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).
PubMed
Journal
N Engl J Med
PubMed
Year
1991
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
1,289
iCite
Relative citation ratio, by iCite
29.2
iCite
Revised in PubMed
2022-04-08
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Warrell RP JrR P
2Frankel SRS R
3Miller WH JrW H
4Scheinberg DAD A
5Itri LML M
6Hittelman WNW N
7Vyas RR
8Andreeff MM
9Tafuri AA
10Jakubowski AA

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Leukemia, Promyelocytic, AcuteMajor topic
TretinoinMajor topic
Administration, Oral
Adolescent
Adult
Aged
Carrier Proteins
Child
Chromosome Aberrations
Female
Flow Cytometry
Humans
Immunoblotting
Leukocyte Count
Male
Middle Aged
Neoplasm Proteins
Receptors, Retinoic Acid
Remission Induction

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA-09207-14NCI NIH HHSUnited StatesPubMedPubMed
FD-R-000674FDA HHSUnited StatesPubMedPubMed
R01FD000674NIHNIH RePORTER
T32CA009207NIHNIH RePORTER

Download CSV of grants

Cited by272

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,289 citations.

PMIDTitleJournalYearIn PapersSource
42433709Fenretinide in cancer therapy and chemoprevention: past, present and future.Cancer Drug Resist2026https://conductscience.org/library/papers/42433709PubMed
42329216An optimized method to differentiate HL60 cells into neutrophil-like cells.J Leukoc Biol2026https://conductscience.org/library/papers/42329216PubMed
42131682Isotretinoin Use During Consolidation in Acute Promyelocytic Leukemia Following Standard All-Trans Retinoic Acid (ATRA)-Based Induction: A Case Report.Cureus2026https://conductscience.org/library/papers/42131682PubMed
42062396Differential regulation of retinoic acid metabolism in Fanconi anemia.Sci Rep2026https://conductscience.org/library/papers/42062396PubMed
41542487AN OPTIMIZED METHOD TO DIFFERENTIATE HL60 CELLS INTO NEUTROPHIL-LIKE CELLS.bioRxiv2026https://conductscience.org/library/papers/41542487PubMed
41279885Virtual Clinical Trials of BMP4 Differentiation Therapy: Digital Twins to Aid Successful Glioblastoma Trial Design.bioRxiv2025https://conductscience.org/library/papers/41279885PubMed
41239429Early mortality in patients with acute promyelocytic leukemia: a systematic review and meta-analysis.Crit Care2025https://conductscience.org/library/papers/41239429PubMed
40505660Derepressing nuclear pyruvate dehydrogenase induces therapeutic cancer cell reprogramming.Cell Metab2025https://conductscience.org/library/papers/40505660PubMed
40141362Prolonged Low-Dose Administration of FDA-Approved Drugs for Non-Cancer Conditions: A Review of Potential Targets in Cancer Cells.Int J Mol Sci2025https://conductscience.org/library/papers/40141362PubMed
39687864Chaperone-mediated autophagy as a modulator of aging and longevity.Front Aging2024https://conductscience.org/library/papers/39687864PubMed
39682277Acute Promyelocytic Leukemia in the Real World: Understanding Outcome Differences and How We Can Improve Them.Cancers (Basel)2024https://conductscience.org/library/papers/39682277PubMed
38952949Acute myeloid leukemia with a novel AKAP9::PDGFRA fusion transformed from essential thrombocythemia: A case report and mini review.Leuk Res Rep2024https://conductscience.org/library/papers/38952949PubMed
38611029History of Developing Acute Promyelocytic Leukemia Treatment and Role of Promyelocytic Leukemia Bodies.Cancers (Basel)2024https://conductscience.org/library/papers/38611029PubMed
38431691Inhibition of mitochondrial folate metabolism drives differentiation through mTORC1 mediated purine sensing.Nat Commun2024https://conductscience.org/library/papers/38431691PubMed
38275101The phenotypic reversion of cancer: Experimental evidences on cancer reversibility through epigenetic mechanisms (Review).Oncol Rep2024https://conductscience.org/library/papers/38275101PubMed
38272890Generation of a new therapeutic D-peptide that induces the differentiation of acute myeloid leukemia cells through A TLR-2 signaling pathway.Cell Death Discov2024https://conductscience.org/library/papers/38272890PubMed
37963209Lineage Plasticity: The New Cancer Hallmark on the Block.Cancer Res2024https://conductscience.org/library/papers/37963209PubMed
37745860Characterization and therapeutic perspectives of differentiation-inducing therapy in malignant tumors.Front Genet2023https://conductscience.org/library/papers/37745860PubMed
37689790A novel retinoic acid receptor-γ agonist antagonizes immune checkpoint resistance in lung cancers by altering the tumor immune microenvironment.Sci Rep2023https://conductscience.org/library/papers/37689790PubMed
37597697Discovery of 5-sulfonyltetrazoles as neuroblastoma differentiation agents.Bioorg Med Chem Lett2023https://conductscience.org/library/papers/37597697PubMed

See all 272 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
RARA5914PubTator's text mininghttps://conductscience.org/library/genes/5914

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1850498

GET https://conductscience.org/api/papers/v1/1850498/cited_by?page=2